Your search history is turned on.
Date: February 29, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario
FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Sarah Zilik, Chief Financial Officer of Britannia Life Sciences Inc. (formerly RISE Life Science Corp.), certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Britannia Life Sciences Inc. (for...
FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Peter Shippen, Chief Executive Officer of Britannia Life Sciences Inc. (formerly RISE Life Science Corp.), certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Britannia Life Sciences Inc. (f...
Microsoft Word - BBCH Draft MD&A - June 30, 2021 Britannia Life Sciences Inc. Management's Discussion and Analysis For the Nine Months Ended December 31, 2023 and December 31, 2022 1 Managements Discussion and Analysis The following managements discussion and analysis (MD&A) is current to February 29, 2024 and should be read in conj...
Microsoft Word - BLS Draft FS - March 31 2022 Z6 _ SZ 26072022 ` Condensed Interim Consolidated Financial Statements (Expressed in Canadian Dollars) Britannia Life Sciences Inc. December 31, 2023 and 2022 Britannia Life Sciences Inc. Responsibility for Condensed Inter...
Date: November 29, 2023 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario
Britannia Life Sciences Inc. Announces Second Quarter Results Toronto, Ontario--(Newsfile Corp. - November 29, 2023) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia" or the "Company") is pleased to provide its unaudited financial results for the three- and six- month periods ended September 30, 2023. These filings and additional information regarding Britannia are available for ...
NOTE TO READER In contrast to the certificate required for non-venture issuers under National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings (NI 52-109), this Venture Issuer Basic Certificate does not include representations relating to the establishment and maintenance of disclosure controls and procedures (DC&P) and internal contr...
Microsoft Word - BBCH Draft MD&A - June 30, 2021 Britannia Life Sciences Inc. Management's Discussion and Analysis For the Six Months Ended September 30, 2023 and September 30, 2022 1 Managements Discussion and Analysis The following managements discussion and analysis (MD&A) is current to November 29, 2023 and should be read in con...
Microsoft Word - BLS Draft FS - March 31 2022 Z6 _ SZ 26072022 ` Condensed Interim Consolidated Financial Statements (Expressed in Canadian Dollars) Britannia Life Sciences Inc. September 30, 2023 and 2022 Britannia Life Sciences Inc. Responsibility for Condensed Inte...
Date: November 6, 2023 Jurisdictions: Alberta, British Columbia, Manitoba, Ontario
Britannia Provides Update on Mining Division Including Britannia Mining Solutions and Paragon Geochemical Britannia Mining Solutions is a partially owned subsidiary of Britannia Life Sciences Britannia Mining Solutions owns Paragon Geochemical, a full-service, state-of-the-art lab in Sparks, Nevada providing services to the mining industry Britannia Mining Solutions has signed contracts ...